Vagus nerve dysfunction is a broad clinical concept covering any condition where the vagus nerve fails to regulate its target organs properly. Because the vagus nerve innervates the heart, lungs, larynx, pharynx, and the entire gastrointestinal tract, dysfunction can present as cardiac, respiratory, digestive, or voice symptoms — often in combination — making it one of the most diagnostically challenging areas in autonomic medicine.
What Vagus Nerve Dysfunction Actually Means
The vagus nerve carries approximately 80% afferent (sensory) fibres and 20% efferent (motor) fibres. Dysfunction can affect either direction, or both.
Efferent dysfunction impairs the vagus nerve’s motor output to target organs. Cardiac efferent dysfunction produces reduced heart rate variability and resting tachycardia. Gastrointestinal efferent dysfunction produces gastroparesis and intestinal dysmotility. Laryngeal efferent dysfunction produces vocal cord paresis or paralysis.
Afferent dysfunction impairs the sensory signals travelling from the organs back to the brainstem. This is harder to measure clinically but may manifest as impaired satiety signalling (the vagal afferents from the gut that tell the brain you are full), blunted baroreflex sensitivity (the vagal afferents from the aortic arch and carotid body that regulate blood pressure), and altered interoception — the subjective sense of what is happening inside the body. Impaired vagal afferent function has been linked to functional gastrointestinal disorders, anxiety, and depression.
Central processing dysfunction involves the brainstem nuclei that receive and integrate vagal information — the nucleus tractus solitarius (NTS), dorsal motor nucleus, and nucleus ambiguus. Brainstem pathology (stroke, tumour, demyelination) can impair vagal function even when the peripheral nerve is intact.
Causes
Diabetes is the most common cause of vagal neuropathy worldwide. Diabetic autonomic neuropathy affects the vagus nerve early, often before peripheral somatic neuropathy becomes clinically apparent. Cardiac autonomic neuropathy (reduced HRV, resting tachycardia, exercise intolerance) is present in approximately 20% of type 2 diabetics at diagnosis. Gastrointestinal autonomic neuropathy causes diabetic gastroparesis, affecting 20-50% of people with longstanding diabetes. The mechanism is both metabolic (hyperglycaemia-induced oxidative stress damaging small nerve fibres) and vascular (microangiopathy affecting the vasa nervorum).
Post-viral vagal neuropathy. Multiple viruses can cause vagal dysfunction — COVID-19 has been the most studied since 2020. Post-COVID vagal neuropathy presents with tachycardia, orthostatic intolerance, gastroparesis, voice changes, and breathing pattern disorder. Research published in 2023 using high-resolution ultrasound demonstrated measurable vagal nerve swelling in long-COVID patients with autonomic symptoms. Other viruses implicated include EBV, herpes zoster (particularly when reactivating in the distribution of cranial nerves), and influenza.
Autoimmune autonomic neuropathy. Autoimmune autonomic ganglionopathy (AAG), mediated by antibodies against ganglionic acetylcholine receptors, can produce severe pandysautonomia including profound vagal failure — orthostatic hypotension, gastroparesis, constipation, dry mouth, and fixed heart rate. Testing for anti-gAChR antibodies should be considered in any patient with subacute onset of multisystem autonomic failure.
Surgical injury. Thyroidectomy (recurrent laryngeal nerve), fundoplication (vagal trunk damage causing post-surgical gastroparesis), and truncal vagotomy (historically performed for peptic ulcer disease) are common iatrogenic causes.
Neurodegenerative diseases. Parkinson’s disease involves alpha-synuclein deposition in the dorsal motor nucleus of the vagus before motor symptoms appear — the Braak hypothesis proposes that Parkinson’s pathology may begin in the enteric nervous system and spread to the brain via the vagus nerve. Vagal dysfunction (constipation, reduced HRV) often predates motor symptoms by years.
Chronic stress and functional impairment. Sustained sympathetic activation suppresses vagal output without structural nerve damage. This functional impairment is measurable (reduced HRV, impaired vagal reactivity) and reversible with appropriate intervention. It is distinct from neuropathy but can produce similar symptoms — digestive sluggishness, poor stress recovery, sleep disruption, and low-grade inflammation.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,684 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Diagnosis
There is no single “vagus nerve dysfunction test.” Diagnosis requires matching symptoms to objective measures of vagal function.
Heart rate variability is the most accessible screening tool. Reduced RMSSD (the time-domain metric most specific to vagal function) at rest suggests impaired cardiac vagal output. However, low HRV is not specific to vagal neuropathy — it also occurs with deconditioning, stress, poor sleep, and numerous other conditions.
Cardiovascular autonomic reflex tests — heart rate response to deep breathing, Valsalva ratio, and 30:15 ratio on standing — are the standard clinical measures of cardiac vagal function. These tests are quantified and age-normalised. An abnormal deep breathing test (reduced R-R interval variation during paced breathing at 6 breaths per minute) is the earliest and most sensitive marker of cardiac vagal neuropathy.
Gastric emptying study (scintigraphy or 13C breath test) diagnoses gastroparesis — delayed gastric emptying beyond 90 minutes at 4 hours on scintigraphy.
Laryngoscopy identifies vocal cord paresis or paralysis, confirming recurrent laryngeal nerve involvement.
Vagus nerve ultrasound is an emerging tool. Cross-sectional area measurement of the cervical vagus nerve can identify nerve swelling (suggesting acute neuropathy) or atrophy (suggesting chronic damage). Normative values have been established in recent studies, and the technique is becoming more widely available in specialised autonomic centres.
Antibody testing (anti-gAChR, anti-neuronal antibodies, comprehensive autoimmune panels) should be performed when the cause of dysfunction is unclear, particularly with subacute onset.
Treatment
Treatment targets both the underlying cause and the symptomatic consequences of vagal dysfunction.
Cause-specific treatment: Glucose optimisation for diabetic neuropathy. Immunotherapy (IVIG, plasma exchange, rituximab) for autoimmune causes. Time and supportive rehabilitation for post-viral neuropathy. Surgical repair or vocal cord medialization for iatrogenic injury.
Cardiac symptoms: Beta-blockers or ivabradine for inappropriate sinus tachycardia. Salt and fluid loading plus compression garments for orthostatic intolerance. Graded exercise rehabilitation starting with recumbent exercise.
Gastrointestinal symptoms: Dietary modification (small, frequent, low-fat, low-fibre meals) for gastroparesis. Prokinetics (metoclopramide, domperidone, prucalopride). Gastric electrical stimulation (Enterra) for refractory cases.
Vagal rehabilitation: Regardless of cause, behavioural vagal exercises — slow breathing, cold face exposure, gargling, humming — support functional recovery. These exercises activate vagal motor and sensory pathways and may promote neuroplastic compensation even when full nerve recovery is not possible. Daily HRV monitoring provides objective feedback on progress.
Vagus nerve dysfunction spans a wide range of conditions. For the complete guide to vagal anatomy, testing, and practical rehabilitation techniques, get the Vagus Nerve & Me eBook.




